|
|
TTD Drug ID:
DNC011084
Drug
Information |
Name | (S)-enastron | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C14H14N2O2S/c17-9-4-1-3-8(7-9)13-12-10(15-14(19)16-13)5-2-6-11 (12)18/h1,3-4,7,13,17H,2,5-6H2,(H2,15,16,19)/t13-/m0/s1 | InChIKey | BJTGVSGWTIUCSM-ZDUSSCGKSA-N | Canonical SMILES | C1CC2=C(C(NC(=S)N2)C3=CC(=CC=C3)O)C(=O)C1 | Isomeric SMILES | C1CC2=C([C@@H](NC(=S)N2)C3=CC(=CC=C3)O)C(=O)C1 | Target | Kinesin-like protein 1 |  | Inhibitor | [1] | Ref 1 | J Med Chem. 2010 Aug 12;53(15):5676-83.Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|